Healthcare

APAC Molecular Diagnostics Market, Forecast to 2021

Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

INDUSTRY
Healthcare

RELEASE DATE
23-Mar-2017
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
P92E-01-00-00-00
SKU
HC02780-AP-MR_19822
Yes
SHARE

APAC Molecular Diagnostics Market, Forecast to 2021
Published on: 23-Mar-2017 | SKU: HC02780-AP-MR_19822

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identified Asia as a market for future growth but have significantly invested in R&D efforts to cater to the Asian population. Genomic studies on Asian population in disease areas like oncology for targeted therapies are constantly on a rise, with active efforts from pharmaceutical and IVD companies. The rise of the private healthcare sector in Asia, with the improvement of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region.

The total MDx industry has been segmented into 4 major areas: infectious diseases, oncology, genetic disorders, and pharmacogenomics. The APAC MDx market was worth $1.72 Billion in 2016 and is expected to reach $2.86 Billion by 2021, at a CAGR of 10.7%. Infectious disease represents the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%) and pharmacogenomics (3.7%).

Cancer incidence has gone up significantly in Asia. Under genetic disorders, non-invasive prenatal testing (NIPT) has great potential with excellent opportunities for future growth. On the technology front, conventional PCR technology is being upgraded with multiplexing capabilities and introduction of automated solutions to cater to high volumes. NGS solutions are gradually making inroads into Asia, especially in developed markets like Singapore, Japan, and South Korea.

This study highlights the growing prominence of MDx industry in Asia, regional trends, growth opportunities, competitive dynamics, and a regional chapter for each of the 11 countries covered in this study.

Area of opportunity in MDx market in the APAC:
• The MDx market in the APAC is evolving with increasing access to established NATs in emerging countries as a result of revamped healthcare practices across the region.
• Oncology care has taken a new dimension in APAC, with the simultaneous rise in prevalence and demand for innovative drugs beyond conventional chemotherapy drugs.
• CDx based oncology drugs are on the rise in the region, with studies targeted for Asian population to demonstrate value. For example, Ono Pharmaceutical’s research on identifying a CDx for Opdivo, introduced in 2014 to stratify patient population.
• Novel genomic tools and technologies are foraying into the APAC to harness the future growth opportunities in the dynamic healthcare ecosystem.

Key questions this study will answer:
• What is the impact of MDx on the IVD industry, given the present healthcare scenario in the APAC?
• Who are the key industry participants in this highly fragment market?
• What are multiple factors impending the growth of MDx in the APAC?
• What are the service delivery models adapted by stakeholders across this region?
• What are the market access strategies for MDx companies aspiring to enter the APAC?
• What is the future of the molecular diagnostics market in the APAC?

Forecast Methodology

Key Findings

Scope and Segmentation

Market Engineering Measurements

Market Overview—Definitions

8 Big Market Themes for APAC MDx

Trends/Factors Impacting the APAC MDx Market

Key Companies to Watch

Key Predictions

MDx—Transition from Present to Future

Market Segmentation

Market Overview—Segmentation by Application

Role of Molecular Biomarkers in Pharma R&D

Market Overview—Life Cycle Analysis

Key Mergers, Acquisitions, & Partnerships

Market Drivers

Market Restraints

Market Engineering Measurements

Total Molecular Diagnostics Market—Revenue Forecast

Percent Revenue Forecast by Country

Revenue Forecast by Country

Snapshot of Market Participants

Market Snapshot

Market Share by Companies

Competitive Positioning—Seegene

Competitive Positioning—Roche

Competitive Positioning—ThermoFisher

Competitive Positioning—Qiagen

Competitive Positioning—Sysmex

Growth Opportunities—Synergy of 3Ps in APAC

Growth Opportunities—Clinical Trials Market in APAC

Growth Opportunities

Trends for the Adoption of MDx Services in APAC

Future Trends—Direct to Consumer Testing

Future Trends—Niche Clusters to Watch Out for

Future Trends—Point-of-Care Testing (POCT) in MDx

Future Trends—Lifestyle Genomics in APAC

Genome Asia-100K

Polymerase Chain Reaction (PCR)

PCR—Technology Snapshot

In-situ Hybridization (ISH)

Next-Generation Sequencing (NGS)

Cost Implications of NGS

Future of NGS Platform

Drivers for Technology Platforms

MDx Test by Application Scenarios

Infectious Disease Segment—Revenue Forecast

Oncology Segment—Revenue Forecast

Genetic Disorders Segment—Revenue Forecast

Pharmacogenomics Segment—Revenue Forecast

Market Engineering Measurements

China Market—Revenue Forecast

China—Market Drivers

China—Market Restraints

Competitive Structure

Market Engineering Measurements

South Korea Market—Revenue Forecast

South Korea—Market Drivers

South Korea—Market Restraints

Competitive Structure

Market Engineering Measurements

India Market—Revenue Forecast

India—Market Drivers

India—Market Restraints

India—Market Restraints

Market Engineering Measurements

Japan Market—Revenue Forecast

Japan—Market Drivers

Japan—Market Restraints

Competitive Structure

Market Engineering Measurements

Australia Market—Revenue Forecast

Australia—Market Drivers

Australia—Market Restraints

Competitive Structure

Market Engineering Measurements

Taiwan Market—Revenue Forecast

Taiwan—Market Drivers

Taiwan—Market Restraints

Competitive Structure

Market Engineering Measurements

Indonesia Market—Revenue Forecast

Indonesia—Market Drivers

Indonesia—Market Restraints

Competitive Structure

Market Engineering Measurements

Malaysia Market—Revenue Forecast

Malaysia—Market Drivers

Malaysia—Market Restraints

Competitive Structure

Key Trends—Challenges and Opportunities

Market Engineering Measurements

Thailand Market—Revenue Forecast

Thailand—Market Drivers

Thailand—Market Restraints

Competitive Structure

Market Engineering Measurements

Singapore Market—Revenue Forecast

Singapore—Market Drivers

Singapore—Market Restraints

Competitive Structure

Market Engineering Measurements

Philippines Market—Revenue Forecast

Philippines—Market Drivers

Philippines—Market Restraints

Competitive Structure

Market Engineering Measurements

Vietnam Market—Revenue Forecast

Vietnam—Market Drivers

Vietnam—Market Restraints

Competitive Structure

The Last Word—Three Big Predictions

Key Conclusions

Legal Disclaimer

Market Engineering Methodology

List of Figures
  • 1. Total Molecular Diagnostics Market: Key Market Drivers, APAC, 2017–2021
  • 2. Total Molecular Diagnostics Market: Key Market Restraints, APAC, 2017–2021
  • 3. Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016
  • 4. Total Molecular Diagnostics Market: Revenue Forecast by Country, APAC, 2014–2021
  • 5. Total Molecular Diagnostics Market: POCT Platforms and Assay Availability by Top Manufacturers, APAC, 2016
  • 6. Total Molecular Diagnostics Market: PCR Platforms from Major Companies, APAC, 2016
  • 7. Total Molecular Diagnostics Market: Companion Diagnostic Tests for Different Cancer Types, APAC, 2016
  • 8. Total Molecular Diagnostics Market: Comparison of Sanger Sequencing and NGS, APAC, 2016
  • 9. Total Molecular Diagnostics Market: Overview of Technology Platforms in MDx, APAC, 2016
  • 10. Molecular Diagnostics Industry: Market Engineering Measurements, China, 2016
  • 11. Molecular Diagnostics Market: Drivers, China, 2017–2021
  • 12. Molecular Diagnostics Market: Restraints, China, 2017–2021
  • 13. Molecular Diagnostics Market: Competitive Structure, China, 2016
  • 14. Molecular Diagnostics Market: Market Engineering Measurements, South Korea, 2016
  • 15. Molecular Diagnostics Market: Drivers, South Korea, 2017–2021
  • 16. Molecular Diagnostics Market: Restraints, South Korea, 2017–2021
  • 17. Molecular Diagnostics Market: Competitive Structure, South Korea, 2016
  • 18. Molecular Diagnostics Market: Market Engineering Measurements, India, 2016
  • 19. Molecular Diagnostics Market: Drivers, India, 2017–2021
  • 20. Molecular Diagnostics Market: Restraints, India, 2017–2021
  • 21. Molecular Diagnostics Market: Competitive Structure, India, 2016
  • 22. Molecular Diagnostics Market: Market Engineering Measurements, Japan, 2016
  • 23. Molecular Diagnostics Market: Drivers, Japan, 2017–2021
  • 24. Molecular Diagnostics Market: Restraints, Japan, 2017–2021
  • 25. Molecular Diagnostics Market: Competitive Structure, Japan, 2016
  • 26. Molecular Diagnostics Market: Market Engineering Measurements, Australia, 2016
  • 27. Molecular Diagnostics Market: Drivers, Australia, 2017–2021
  • 28. Molecular Diagnostics Market: Restraints, Australia, 2017–2021
  • 29. Molecular Diagnostics Market: Competitive Structure, Australia, 2016
  • 30. Molecular Diagnostics Market: Market Engineering Measurements, Taiwan, 2016
  • 31. Molecular Diagnostics Market: Drivers, Taiwan, 2017–2021
  • 32. Molecular Diagnostics Market: Restraints, Taiwan, 2017–2021
  • 33. Molecular Diagnostics Market: Restraints, Taiwan, 2017–2021
  • 34. Molecular Diagnostics Market: Market Engineering Measurements, Indonesia, 2016
  • 35. Molecular Diagnostics Market: Drivers, Indonesia, 2017–2021
  • 36. Molecular Diagnostics Market: Restraints, Indonesia, 2017–2021
  • 37. Molecular Diagnostics Market: Competitive Structure, Indonesia, 2016
  • 38. Molecular Diagnostics Market: Market Engineering Measurements, Malaysia, 2016
  • 39. Molecular Diagnostics Market: Drivers, Malaysia, 2017–2021
  • 40. Molecular Diagnostics Market: Restraints, Malaysia, 2017–2021
  • 41. Molecular Diagnostics Market: Competitive Structure, Malaysia, 2016
  • 42. Molecular Diagnostics Market: Market Engineering Measurements, Thailand, 2016
  • 43. Molecular Diagnostics Market: Drivers, Thailand, 2017–2021
  • 44. Molecular Diagnostics Market: Restraints, Thailand, 2017–2021
  • 45. Molecular Diagnostics Market: Competitive Structure, Thailand, 2016
  • 46. Molecular Diagnostics Market: Market Engineering Measurements, Singapore, 2016
  • 47. Molecular Diagnostics Market: Drivers, Singapore, 2017–2021
  • 48. Molecular Diagnostics Market: Restraints, Singapore, 2017–2021
  • 49. Molecular Diagnostics Market: Competitive Structure, Singapore, 2016
  • 50. Molecular Diagnostics Market: Market Engineering Measurements, Philippines, 2016
  • 51. Molecular Diagnostics Market: Drivers, Philippines, 2017–2021
  • 52. Molecular Diagnostics Market: Restraints, Philippines, 2017–2021
  • 53. Molecular Diagnostics Market: Competitive Structure, Philippines, 2016
  • 54. Molecular Diagnostics Market: Market Engineering Measurements, Vietnam, 2016
  • 55. Molecular Diagnostics Market: Drivers, Vietnam, 2017–2021
  • 56. Molecular Diagnostics Market: Restraints, Vietnam, 2017–2021
  • 57. Molecular Diagnostics Market: Competitive Structure, Vietnam, 2016
List of Charts
  • 1. Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016
  • 2. Total Molecular Diagnostics Market: Roles of Biomarkers in the Pharmaceutical Value Chain, APAC, 2016
  • 3. Total Molecular Diagnostics Market: Future of Molecular Diagnostics Industry, APAC, 2016
  • 4. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Application, APAC, 2016
  • 5. Total Molecular Diagnostics Market: Roles of Biomarkers in Pharmaceutical Value Chain, APAC, 2016
  • 6. Total Molecular Diagnostics Market: Life Cycle Analysis, APAC, 2016
  • 7. Total Molecular Diagnostics Market: Key Mergers, Acquisitions and Partnerships, APAC, 2015–2021
  • 8. Total Molecular Diagnostics Market: Revenue Forecast, APAC, 2014–2021
  • 9. Total Molecular Diagnostics Market: Percent Revenue by Country, APAC, 2016
  • 10. Total Molecular Diagnostics Market: Percent Revenue Forecast by Country, APAC, 2021
  • 11. Total Molecular Diagnostics Market: Key Market Participants, APAC, 2016
  • 12. Total Molecular Diagnostics Market: Percent Revenue by Companies, APAC, 2016
  • 13. Total Molecular Diagnostics Market: Snapshot of Emerging Lifestyle Genetic Tests, APAC, 2016
  • 14. Total Molecular Diagnostics Market: MDx Tests in Different Applications, APAC, 2016
  • 15. Infectious Disease Segment: Revenue Forecast, APAC, 2014–2021
  • 16. Oncology Segment: Revenue Forecast, APAC, 2014–2021
  • 17. Genetic Disorders Segment: Revenue Forecast, APAC, 2014–2021
  • 18. Pharmacogenomics Segment: Revenue Forecast, APAC, 2014–2021
  • 19. Molecular Diagnostics Market: Revenue Forecast, China, 2014–2021
  • 20. Molecular Diagnostics Market: Revenue Forecast, South Korea, 2014–2021
  • 21. Molecular Diagnostics Market: Revenue Forecast, India, 2014–2021
  • 22. Molecular Diagnostics Market: Revenue Forecast, Japan, 2014–2021
  • 23. Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021
  • 24. Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021
  • 25. Molecular Diagnostics Market: Revenue Forecast, Indonesia, 2014–2021
  • 26. Molecular Diagnostics Market: Revenue Forecast, Malaysia, 2014–2021
  • 27. Molecular Diagnostics Market: Revenue Forecast, Thailand, 2014–2021
  • 28. Molecular Diagnostics Market: Revenue Forecast, Singapore, 2014–2021
  • 29. Molecular Diagnostics Market: Revenue Forecast, Philippines, 2014–2021
  • 30. Molecular Diagnostics Market: Revenue Forecast, Vietnam, 2014–2021

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.